Schedule 13D ownership disclosure
Qualigen Therapeutics, Inc.
Common Stock, par value $0.001 per share · CUSIP: 74754R103
Event date: 2025-11-17
- Filing-level shares
- 1,227,147.00
- Percent of class
- 19.99%
- FARADAY FUTURE INTELLIGENT ELECTRIC INC.Reported CIK 0001805521
Shares: 1,227,147.00 · Class: 19.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-112721
- Form type
- SCHEDULE 13D/A
- Filer
- FARADAY FUTURE INTELLIGENT ELECTRIC INC.
- CIK
- CIK 1805521
- Filed
- Nov 19, 2025
- Reporting period
- Nov 17, 2025
- Description
- Schedule 13D beneficial ownership